Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
05 March 2014 to 10 April 2014
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Test animals

Species:
rat
Strain:
other: RccHan:(WIST)
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 11 weeks (at test item administration)
- Weight at study initiation: females 182 – 193 g
- Fasting period before study: overnight
- Housing: 3 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 21 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.4 – 24.1 °C
- Humidity (%): 32-59%
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 26.03.2014 To: 10.04.2014

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Remarks:
400
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg bw
- Lot/batch no. (if required): BCBJ7623V
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3 female animals per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily thereafter
- Frequency of weighing: on -1day, 0 day and 7 day
- Necropsy of survivors performed: yes
- Other examinations performed: All animals were subjected to a necropsy and a macroscopic examination.

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
Oxophos 64i did not cause mortality at a dose level of 2000 mg/kg bw.
Clinical signs:
other: Treatment with Oxophos 64i at the dose level of 2000 mg/kg bw did not cause any clinical signs during the 14 days observation period.
Gross pathology:
No macroscopic observations were present at a dose level of 2000 mg/kg bw

Any other information on results incl. tables

Animal supplier: Harlan Laboratories S.r.l., S.Pietro al Natisone (UD), Zona Industriale Azzida, 57 33040, Italy

Applicant's summary and conclusion

Interpretation of results:
study cannot be used for classification
Remarks:
Migrated information
Conclusions:
Under the conditions of this study, the acute oral LD50 value of the test item Oxophos 64i was found to be above 2000 mg/kg bw in female
RccHan:(WIST) rats.